Christopher O’Callaghan
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Cystic Fibrosis Research Advances
- Inhalation and Respiratory Drug Delivery
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Cystic Fibrosis Research Advances 78
- Inhalation and Respiratory Drug Delivery 63
- Genetics 28
- Genetic and Kidney Cyst Diseases 24
- Co-authors
- Robert Anthony Hirst (51 shared papers)Peter W. Barry (13 shared papers)Andrew Rutman (21 shared papers)Anthony David Milner (14 shared papers)PW Barry (6 shared papers)P W Barry (11 shared papers)Peter William Andrew (17 shared papers)Andrew Bush (9 shared papers)
- Journals
- European Respiratory Journal (23 papers)Archives of Disease in Childhood (20 papers)Thorax (14 papers)The Lancet (8 papers)CHEST Journal (8 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Christopher O’Callaghan
245 papers receiving 13.1k citations
Christopher O’Callaghan's Hit Papers
Peers
Comparison fields: 5 of 168
- Pulmonary and Respiratory Medicine 6k
- Infectious Diseases 2.5k
- Genetics 1.5k
- Microbiology 228
- Physiology 889
Countries citing papers authored by Christopher O’Callaghan
This map shows the geographic impact of Christopher O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher O’Callaghan more than expected).
Fields of papers citing papers by Christopher O’Callaghan
This network shows the impact of papers produced by Christopher O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher O’Callaghan. The network helps show where Christopher O’Callaghan may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher O’Callaghan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 1531 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children Hit paper breakdown → | 2009 | 408 |
| 4 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 5 | 1998 | 308 | |
| 6 | 2009 | 289 | |
| 7 | 2010 | 284 | |
| 8 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 9 | 2007 | 271 | |
| 10 | 1997 | 256 | |
| 11 | 2021 | 240 | |
| 12 | 2012 | 231 | |
| 13 | 2008 | 220 | |
| 14 | 2021 | 213 | |
| 15 | 2012 | 211 | |
| 16 | 2014 | 201 | |
| 17 | 2016 | 178 | |
| 18 | 2004 | 171 | |
| 19 | 2012 | 165 | |
| 20 | 2010 | 164 |
About Christopher O’Callaghan
Christopher O’Callaghan is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Epidemiology, Physiology and Microbiology, having authored 254 papers that have together received 13.9k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (78 papers), Inhalation and Respiratory Drug Delivery (63 papers), Genetic and Kidney Cyst Diseases (24 papers), Asthma and respiratory diseases (18 papers), Respiratory viral infections research (12 papers), Pneumonia and Respiratory Infections (11 papers), Bacterial Infections and Vaccines (10 papers) and Cerebrospinal fluid and hydrocephalus (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6k citations), Infectious Diseases (2.5k citations), Genetics (1.5k citations), Microbiology (228 citations) and Physiology (889 citations). Christopher O’Callaghan has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Robert Anthony Hirst, Peter W. Barry, Andrew Rutman, Anthony David Milner, PW Barry, P W Barry, Peter William Andrew, Andrew Bush, Alexander Swarbrick and Mark A. Chilvers. Their work appears in journals such as European Respiratory Journal, Archives of Disease in Childhood, Thorax, The Lancet and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.